GW&K Investment Management Reduces Stake in Globus Medical

Institutional investor sells over 72,000 shares of medical device company

Published on Mar. 5, 2026

Got story updates? Submit your updates here. ›

GW&K Investment Management LLC reduced its stake in Globus Medical, Inc. (NYSE:GMED) by 3.9% during the third quarter, according to a recent SEC filing. The firm now owns 1,777,431 shares of the medical device company's stock, making it the 17th largest holding in its portfolio.

Why it matters

Globus Medical is a leading manufacturer of spinal implants and surgical instruments. Changes in institutional ownership can signal shifts in investor sentiment and impact the company's stock price and access to capital.

The details

According to the SEC filing, GW&K Investment Management sold 72,271 shares of Globus Medical during the third quarter. The firm now owns about 1.32% of the company's outstanding shares, valued at $101.8 million as of the most recent filing. Globus Medical's stock has seen significant volatility over the past year, trading between $51.79 and $101.40 per share.

  • GW&K Investment Management reduced its stake in Globus Medical during the third quarter of 2025.

The players

GW&K Investment Management LLC

An institutional investment management firm that owns a significant stake in Globus Medical.

Globus Medical, Inc.

A leading medical device company specializing in musculoskeletal solutions for spine and orthopedic applications.

Got photos? Submit your photos here. ›

The takeaway

The reduction in GW&K Investment Management's stake in Globus Medical could signal a shift in investor sentiment towards the medical device company. However, Globus Medical remains a significant holding in the firm's portfolio, indicating continued confidence in the company's long-term prospects.